Solving the nuclear isotopes shortage

Accelerator facilities suggested for hospitals

At the end of January, the of Concerned Scientists issued a call to improve supplies of nuclear isotopes, which is used in medical imaging. In the face of no firm plans to solve these problems, Tom Ruth, of TRIUMF, Vancouver, Canada, has proposed both short and long-term visions for the future in an Essay in the science journal Nature.

Four-fifths of the most widely-used radionuclide comes from just two nuclear reactor facilities: one in the Netherlands; one in Canada. Due to the short half-life of the isotope, stockpiling for more than a couple of days is impossible. Unexpected closures of both of these aging facilities over the past 18 months caused panic and the cancellation of medical procedures. In addition, both facilities make use of highly enriched uranium, seen by some as a terrorism risk.
Ruth’s solution is to replace reactor-made isotopes with ones made from an accelerator. This is cheaper and safer, as it does not involve highly enriched uranium, but requires the Canadian government to take steps to retain its role as a world leader in nuclear medicine. His vision for the future involves equipping more hospitals with their own accelerator facilities, so that different isotopes can be used to produce clearer, better medical images.
Details: www.nature.com/nature. Essay publication date: 29/1/09.
Tom Ruth: truth@triumf.ca

01.03.2009

Read all latest stories

Related articles

Photo

News • Clear cell renal cell cancer

Same-day imaging for ccRCC kidney cancer with new PET agent

A new study suggests superiority of the novel investigational PET imaging agent ⁶⁸Ga-DPI-4452 (Debio 0328) to standard CT imaging in the context of clear cell renal cell cancer (ccRCC).

Photo

News • Missed in MRI

Multiple sclerosis: PET scans reveal 'hidden' inflammation

In some patients with multiple sclerosis (MS), symptoms worsen during treatment, but MRI scans do not indicate any change. In such cases, positron emission tomography could help, a new study suggests.

Photo

News • Nuclear medicine

Prostate cancer: New SPECT/CT technique for greater treatment precision

A new SPECT/CT imaging technique using lead-212 (²¹²Pb) shows promise in targeted alpha therapy (TAT) for patients with metastatic castration-resistant prostate cancer.

Related products

Subscribe to Newsletter